Trials / Terminated
TerminatedNCT05662306
C-Cog in Early Course Schizophrenia Study
Comprehensive Treatment of Early Course Schizophrenia: A Nonrandomized Study of Long Acting Injectable Antipsychotic Medication Combined With Cognitive and Functional Skills Training
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the role of clinical stability in functional recovery. in first episode schizophrenia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aripiprazole Lauroxil | 1064 mg 2-month long-acting injectable administered as an intramuscular injection over a 12-month period. |
| BEHAVIORAL | Computerized cognitive and functional skills training | Self-administered cognitive and technology focused skills training, administered at home for 2 hours per week for the first 12 weeks of the 12-month study period. |
Timeline
- Start date
- 2024-01-23
- Primary completion
- 2025-03-03
- Completion
- 2025-03-03
- First posted
- 2022-12-22
- Last updated
- 2026-02-06
- Results posted
- 2026-02-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05662306. Inclusion in this directory is not an endorsement.